NATCOPHARMA Weekly ChartCup & Handle Breakout
Retest level 935
Taken support 9 EMA and bounced
support 845
RSI above 60 Weekly / Monthly
Daily RSI 58
EMA are in line
Expected level 1189 and above
70.85INR
7.15 BINR
26.99 BINR
89.52 M
About NATCO PHARMA LTD
Sector
CEO
Rajeev Nannapaneni
Headquarters
Hyderabad
Website
Employees (FY)
4.49 K
Founded
1981
ISIN
INE987B01026
FIGI
BBG000F4LTG0
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
Natco Pharma Breakout Retest! 🚀
Hey Dosto! 👋
🔍 Chart Analysis: Natco Pharma - CMP 980 📊
🚀 Reasons for Trade:
Strong Uptrend
Cup and Handle Breakout Retest
💹 Trade Details:
CMP: 980
SL: 918
Targets: 1090, 1188
🌟 Why Natco Pharma? After a cup and handle breakout, Natco Pharma has retraced for a retest, indicating potential upwa
NATCOPHARMA: Potential Reversal candidateNATCO PHARMA made a rounding bottom and later completed the cup and handle pattern.
The stock is trying to reverse from the 38% retracement from the top it made recently. If it reverses we can aim for the target of 1240-1300-1350-1500-1600.
Targets or studies are based on my analysis and shouldn't
Natco Pharma LtdTARGET AND SL @760
FUNDAMENTALS
Market Cap
₹ 14,846 Cr.
Current Price
₹ 829
High / Low
₹ 928 / 502
Stock P/E
13.2
Book Value
₹ 296
Dividend Yield
1.00 %
ROCE
17.7 %
ROE
15.3 %
Face Value
₹ 2.00
Promoter holding
49.7 %
EPS last year
₹ 39.2
EPS latest quarter
₹ 20.6
Debt
₹ 248 Cr.
P
NATCOPHARMA Short Term16-02-2024
--------------
Buy NATCOPHARMA @CMP
Target of 1094-1190-1314-1383
SL 832
Strategy : SBO + RSI > 60 + EMA above 20 & 50
Duration few weeks
Please consult your financial advisor before investing
All research for educational purposes only.
Natco Pharma; can it achieve it?This is about to make breakout of its multi-year w-pattern / volatility contraction.
Pharma being at the good position, makes it more attractive.
With recent financial exceeding estimates indicate that the company is inline with what chart is projecting.
What do you think? Will its price sustain
Natco Long RunFormed a Traditional Double Bottom and also Inverted Head Shoulders.
Once it break the neck point 1189, target will be 1432 and 1670.
NATCOPHARMStock name = Natco Pharma Limited.
Weekly chart setup
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Master Score - B
Disclaimer: This is for demonstration and educa
Natco- LongNatco is trading in a symmetrical triangle chart pattern . It is expected to break towards upside where we can see a rally until 1000 + .
if it break the bottom of the triangle then it dont go for it. Wait for the line breakout and enter.
Disclaimer : Only for learning Purpose and not a trading re
NATCO PHARMA LTD - READY TO BREAKOUTEntry Possible above 950 level
SL - 720
Short term Target - 1190
Long term Target - 1500
Disclaimer - All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taki
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NATCOPHARM is 1006.85 INR — it has increased by 2.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange NATCO PHARMA LTD stocks are traded under the ticker NATCOPHARM.
NATCO PHARMA LTD is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NATCO PHARMA LTD has a max estimate of 1125.00 INR and a min estimate of 620.00 INR.
NATCOPHARM earnings for the last quarter are 20.60 INR whereas the estimation was 18.28 INR which accounts for 12.67% surprise. Estimated earnings for the next quarter are 7.04 INR. See more details about NATCO PHARMA LTD earnings.
NATCO PHARMA LTD revenue for the last quarter amounts to 10.31 B INR despite the estimated figure of 10.49 B INR. In the next quarter revenue is expected to reach 6.11 B INR.
Yes, you can track NATCO PHARMA LTD financials in yearly and quarterly reports right on TradingView.
NATCOPHARM stock has risen by 2.64% compared to the previous week, the month change is a 5.46% rise, over the last year NATCO PHARMA LTD has showed a 77.73% increase.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 4.49 K employees. See our rating of the largest employees — is NATCO PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO PHARMA LTD EBITDA is 16.44 B INR, and current EBITDA margin is 35.90%. See more stats in NATCO PHARMA LTD financial statements.